The future of digital health part 2: Digital patient engagement and virtual healthcare delivery

Part 2

Last week, we started a new series featuring healthcare visionary and thought leader Andy Dé. In this series, Dé discusses how COVID-19 has triggered remarkable digital transformation and uncovers five long-term innovation implications that providers, healthcare leaders, and payers need to consider.

Catch up on the first implication—advanced analytics for vaccine administration—then read on to explore number two in this week’s article.


Innovation implication #2: Digital patient engagement and virtual healthcare delivery

Protecting the health, well-being and safety of healthcare practitioners and first responders is paramount — and will accelerate adoption of Digital Patient Engagement (DPE), enabled by Virtual Healthcare Delivery (VHD) solutions (also known as “Hospital at Home.)”

As pictured below, there are three primary drivers for DPE and VHD:

  1. A clear need to deliver high quality healthcare to a massive number of patients afflicted with a contagious disease and co-morbidities.
  2. Risks presented by acquiring COVID-19 combined with continued lack of sufficient equipment, PPE, and rest for healthcare workers
  3. The need to minimize direct contact of providers with patients while increasing level of care efficiency and productivity

When I have this conversation with healthcare colleagues, the next question I typically receive is: “Andy, this sounds great, but where do we start?” The chart below demonstrates several helpful examples of how technology can be used to transform typical patient interactions and needs:

If you’re interested in more details about how to actually make changes like the ones described above, reach out to start a conversation. Join me back here on the MedeAnalytics blog next week for Innovation implications #3: Artificial intelligence and machine learning for operations, revenue cycle and supply change management innovation and #4: Medical robotics.

Andy Dé

Andy Dé is the Chief Marketing Officer. Andy joined MedeAnalytics in March 2021 bringing more than 20 years of enterprise software product marketing, product management and industry strategy experience. In his role, Andy oversees the company’s go-to-market (GTM) strategy and marketing. He is passionate about healthcare innovation and is recognized as an industry thought leader in healthcare.

Get our take on industry trends

How to help employer groups plan in a time of uncertainty

June 15, 2020

Employers and their sponsored health plans are thinking about next year’s benefit designs with a significant challenge not seen before: the effect of the coronavirus pandemic. There are important considerations to take into account before making any decisions about new or existing coverage. Becky Niehus, a director of Product Consulting at MedeAnalytics, explores these new issues and what employers can do to ensure employees are “covered.”

Read on...

Healthcare’s return to “normal” after COVID-19: Is it possible?

June 9, 2020

As providers determine how to get patients to return to facilities for routine disease management and preventive screenings, opportunities are ripe for the application of analytics to triage at the right time to the right setting. Data related to COVID-19 will continue to flow rapidly, but there are possibly more questions than answers now about a return to “normal.”

Read on...

Avoid COVID-19 modeling pitfalls by eliminating bias, using good data

June 2, 2020

COVID-19 models are being used every day to predict the course and short- and long-term impacts of the pandemic. And we’ll be using these COVID-19 models for months to come.

Read on...

Population Health Amid the Coronavirus Outbreak

May 19, 2020

In speaking with many colleagues throughout the provider and payer healthcare community, I’ve found an overwhelming sense of helplessness to the outbreak’s onslaught. This is exacerbated by the constant evolution of reported underlying medical conditions that indicate a higher risk of hospitalization or mortality for a coronavirus patient.

Read on...